• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,196.25 2,579.67
( 3.46%)
Global Indices
Nasdaq
46,614.19 -76.70
(-0.16%)
Dow Jones
6,639.23 6.40
(0.10%)
Hang Seng
53,529.44 115.76
(0.22%)
Nikkei 225
10,352.49 -83.80
(-0.80%)
Forex
USD-INR
92.93 0.25
(0.27%)
EUR-INR
107.23 0.49
(0.46%)
GBP-INR
122.94 0.71
(0.58%)
JPY-INR
0.58 0.00
(0.32%)

EQUITY - MARKET SCREENER

Remedium Lifecare Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
539561
INE549S01036
1.0300774
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
30.87
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

Nectar Lifescience reports consolidated net loss of Rs 176.01 crore in the September 2025 quarter
Nov 15,2025
Net loss of Nectar Lifescience reported to Rs 176.01 crore in the quarter ended September 2025 as against net profit of Rs 5.60 crore during the previous quarter ended September 2024. Sales declined 12.74% to Rs 5.00 crore in the quarter ended September 2025 as against Rs 5.73 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales5.005.73 -13
OPM %-6.60-10.30 -
PBDT-0.300.10 PL
PBT-0.50-0.35 -43
NP-176.015.60 PL